Proton Therapy and related research activities at HZB

by Andrea Denker (Charité Berlin)

Wednesday, June 26, 2019 from to (Europe/Berlin)
at GSI ( KBW Seminar Room 2.28 )
Since 1998 HZB operates the only proton therapy facility for ocular tumours in Germany. Worldwide only about a dozen of dedicated facilities exist, mainly located at research institutions. At HZB more than 3400 patients have been treated. Treatment planning is based on high resolution CT, MRI, ultrasound, ocular coherence tomography (OCT) and fundus imaging, which is not common for ocular proton therapy. 
The close co-operation between Charité – Universitätsmedizin Berlin and HZB permits joint interdisciplinary research. An experimental station permits irradiations with either a sharp, well focused or a broad beam. In addition, a 60Co-source for γ-irradiations is available. Experiments now comprise dosimetry, detector comparisons, ambulant Mouse irradiations, including class I gene-modified mice. Furthermore, radiation hardness tests on detectors, CCD-cameras and other electronics are performed.
The therapy and results as well as on-going experiments will be presented.